6 Results for "

releas

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "releas" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0283
CAS No.: 51037-30-0
Synonyms: K-9321
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-P1628
CAS No.: 124904-93-4
Target:  

GnRH Receptor

Research Areas:  

Metabolic Disease

Ganirelix is a competitive and selective gonadotropin releasing hormone (GnRH) antagonist. Ganirelix prevents endogenous GnRH from inducing luteinising hormone (LH) and follicle stimulating hormone relea .
loading...
    loading...
Cat. No.: HY-111217
CAS No.: 878983-38-1
Purity:  99.23%
Research Areas:  

Neurological Disease Cancer

AKOS-22 is a potent mitochondrial protein VDAC1 (voltage-dependent anion channel 1) inhibitor (Kd=15.4 μM). AKOS-22 interacts with VDAC1 and inhibiting both VDAC1 oligomerization and apoptosis. AKOS-22 protects against mitochondrial dysfunction .
loading...
    loading...
Cat. No.: HY-B0283A
CAS No.: 76958-97-9
Synonyms: K-9321 sodium
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321) sodium, a nicotinic acid analogue, is an antilipolytic compound. Acipimox sodium stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-B0283R
CAS No.: 51037-30-0
Synonyms: K-9321 (Standard)
Research Areas:  

Metabolic Disease

Acipimox (Standard) is the analytical standard of Acipimox. This product is intended for research and analytical applications. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-111217R
CAS No.: 878983-38-1
AKOS-22 (Standard) is the analytical standard of AKOS-22 (HY-111217). This product is intended for research and analytical applications. AKOS-22 is a potent mitochondrial protein VDAC1 (voltage-dependent anion channel 1) inhibitor (Kd=15.4 μM). AKOS-22 interacts with VDAC1 and inhibiting both VDAC1 oligomerization and apoptosis. AKOS-22 protects against mitochondrial dysfunction .
loading...
    loading...